Michael Goldberg
CIK: 0001366412
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CareDx, Inc.
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Oct 2, 2026CDNA
CareDx, Inc.
Award(A)Direct588 shares- - Aug 4, 2026CDNA
CareDx, Inc.
Sale(S)Direct44.7K shares at avg. $47.06$2.1M - Jul 2, 2026CDNA
CareDx, Inc.
Award(A)Direct1.7K shares- - Jun 12, 2026CDNA
CareDx, Inc.
Award(A)Direct9.8K shares- - Apr 2, 2026CDNA
CareDx, Inc.
Award(A)Direct2K shares- - Mar 31, 2026CDNA
CareDx, Inc.
Exercise(M)Direct5.3K shares at avg. $5.02$26K - Mar 31, 2026CDNA
CareDx, Inc.
Exercise(M)Direct9.7K shares at avg. $4.95$48K - Mar 31, 2026CDNA
CareDx, Inc.
Exercise(M)Direct11.5K shares at avg. $1.22$14K - Jan 6, 2026CDNA
CareDx, Inc.
Award(A)Direct1.5K shares- - Oct 6, 2025CDNA
CareDx, Inc.
Award(A)Direct1.8K shares- - Jul 8, 2025CDNA
CareDx, Inc.
Award(A)Direct1.2K shares- - Jun 13, 2025CDNA
CareDx, Inc.
Award(A)Direct12.1K shares- - Apr 4, 2025CDNA
CareDx, Inc.
Award(A)Direct967 shares- - Jan 6, 2025CDNA
CareDx, Inc.
Award(A)Direct856 shares- - Oct 4, 2024CDNA
CareDx, Inc.
Award(A)Direct837 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 2, 2026 | CDNA CareDx, Inc. | Award(A) | 588 | - | $0 | Direct |
| Aug 4, 2026 | CDNA CareDx, Inc. | Sale(S) | 44,700 | $47.06 | $2,103,497 | Direct |
| Jul 2, 2026 | CDNA CareDx, Inc. | Award(A) | 1,746 | - | $0 | Direct |
| Jun 12, 2026 | CDNA CareDx, Inc. | Award(A) | 9,795 | - | $0 | Direct |
| Apr 2, 2026 | CDNA CareDx, Inc. | Award(A) | 1,981 | - | $0 | Direct |
| Mar 31, 2026 | CDNA CareDx, Inc. | Exercise(M) | 5,255 | $5.02 | $26,380 | Direct |
| Mar 31, 2026 | CDNA CareDx, Inc. | Exercise(M) | 9,745 | $4.95 | $48,238 | Direct |
| Mar 31, 2026 | CDNA CareDx, Inc. | Exercise(M) | 11,500 | $1.22 | $14,030 | Direct |
| Jan 6, 2026 | CDNA CareDx, Inc. | Award(A) | 1,492 | - | $0 | Direct |
| Oct 6, 2025 | CDNA CareDx, Inc. | Award(A) | 1,753 | - | - | Direct |
| Jul 8, 2025 | CDNA CareDx, Inc. | Award(A) | 1,218 | - | - | Direct |
| Jun 13, 2025 | CDNA CareDx, Inc. | Award(A) | 12,103 | - | - | Direct |
| Apr 4, 2025 | CDNA CareDx, Inc. | Award(A) | 967 | - | - | Direct |
| Jan 6, 2025 | CDNA CareDx, Inc. | Award(A) | 856 | - | $0 | Direct |
| Oct 4, 2024 | CDNA CareDx, Inc. | Award(A) | 837 | - | $0 | Direct |
1-15 of 15 transactions
About Goldberg Michael
Goldberg Michael (SEC CIK 0001366412) files insider reports with the SEC as Director of CareDx, Inc. (CDNA).
Signal8 holds 13 ownership filings by Goldberg Michael, all Form 4s, filed between Oct 8, 2024 and Oct 5, 2026. Those filings report 15 transactions, from Oct 4, 2024 to Oct 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Goldberg Michael's filings is in BRISBANE, CA.
Recent filings by Goldberg Michael
- Oct 2, 2026: Grant or award of CDNA shares (Form 4, code A).
- Aug 4, 2026: Open-market sale of CDNA shares (Form 4, code S).
- Jul 2, 2026: Grant or award of CDNA shares (Form 4, code A).
- Jun 12, 2026: Grant or award of CDNA shares (Form 4, code A).
- Apr 2, 2026: Grant or award of CDNA shares (Form 4, code A).
Other insiders filing for CareDx, Inc. (CDNA)
- Novack Jeffrey Adam, Secretary and General Counsel
- Hanna John Walter JR, President and CEO
- Kennedy Keith, CFO & COO
- Meng Jessica, Chief Commercial Officer
- Bickerstaff George, Director
- COURNOYER CHRISTINE, Director